glp 1 parkinson's

glp 1 parkinson's Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Neuroprotective Actions of Glucagon-Like Peptide-1

Name: glp 1 parkinson's Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Neuroprotective Actions of Glucagon-Like Peptide-1
Brand: esh7enle.com
SKU: 23508123286
Price: 20.74 USD
Availability: InStock
Rating: 4.0423 (13 reviews)

SKU: 23508123286

4.0

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

Description

10.1093/oncolo/oyad278 13 Bouman-WammesE

More large long-term RCTs with respiratory disease as the primary outcome are needed in the future to evaluate the link between the incidence of respiratory disease and GLP-1 receptor agonists